[Clinical study on cefdinir in pediatric field].

Author: HachimoriK, KanedaK

Paper Details 
Original Abstract of the Article :
We studied pharmacokinetics and clinical effects of cefdinir (CFDN), a newly developed oral cephalosporin, and the following results were obtained. 1. Pharmacokinetics of CFDN in 2 patients were investigated. The 2 patients with ages of 8 years (36.5 kg, body weight) and 6 years (26.5 kg, body weigh...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元:
https://pubmed.ncbi.nlm.nih.gov/2283717

データ提供:米国国立医学図書館(NLM)

Cefdinir: A Promising New Cephalosporin for Pediatric Infections

Infectious diseases in children can be particularly challenging to manage, requiring safe and effective treatments tailored to their unique needs. This research investigates the pharmacokinetics and clinical effectiveness of cefdinir, a newly developed oral cephalosporin, in pediatric patients. The authors conducted a clinical study to evaluate cefdinir's efficacy and safety in children with various infectious diseases.

Cefdinir: A Safe and Effective Treatment Option for Children

The study's findings demonstrate the safety and efficacy of cefdinir in treating a variety of pediatric infections. The authors observed a high efficacy rate and a favorable safety profile, highlighting the potential of cefdinir as a valuable treatment option for children.

Optimizing Treatment for Pediatric Infections

This research underscores the importance of conducting rigorous clinical trials to evaluate the safety and efficacy of new medications for pediatric patients. The authors' findings provide valuable insights into the potential of cefdinir for pediatric infections, encouraging further research to refine treatment strategies and optimize outcomes for children.

Dr.Camel's Conclusion

This research on cefdinir is like finding a hidden spring in the middle of a dry desert, providing a much-needed source of relief for children suffering from infections. The authors' findings demonstrate the safety and efficacy of cefdinir, making it a promising new option for pediatric treatment. The research offers a clear path forward for optimizing treatment strategies and improving outcomes for children facing infectious diseases.

Date :
  1. Date Completed 1991-03-18
  2. Date Revised 2018-11-30
Further Info :

Pubmed ID

2283717

DOI: Digital Object Identifier

2283717

Related Literature

SNS
PICO Info
in preparation
Languages

Japanese

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.